Isoxazoline-carbocyclic monophosphate nucleotides were designed and synthesized through the chemistry of nitrosocarbonyl intermediates and stable anthracenenitrile oxide. Docking and molecular dynamics studies were first conducted for determining the best candidate for polymerase SARS-CoV-2 inhibition. The setup phosphorylation protocol afforded the nucleotides available for the biological tests. Preliminary inhibition and cytotoxicity assays were then performed, and the results showed a moderate activity of the nucleotides accompanied by cytotoxicity.

Leusciatti, M., Macchi, B., Marino-Merlo, F., Mastino, A., Morra, G., Quadrelli, P. (2023). Inhibition of the RNA-dependent RNA-polymerase from SARS-CoV-2 by 6-chloropurine isoxazoline-carbocyclic monophosphate nucleotides. ACS OMEGA, 8(39), 36311-36320 [10.1021/acsomega.3c04918].

Inhibition of the RNA-dependent RNA-polymerase from SARS-CoV-2 by 6-chloropurine isoxazoline-carbocyclic monophosphate nucleotides

Macchi, Beatrice;
2023-10-03

Abstract

Isoxazoline-carbocyclic monophosphate nucleotides were designed and synthesized through the chemistry of nitrosocarbonyl intermediates and stable anthracenenitrile oxide. Docking and molecular dynamics studies were first conducted for determining the best candidate for polymerase SARS-CoV-2 inhibition. The setup phosphorylation protocol afforded the nucleotides available for the biological tests. Preliminary inhibition and cytotoxicity assays were then performed, and the results showed a moderate activity of the nucleotides accompanied by cytotoxicity.
3-ott-2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore CHIM/08 - Chimica Farmaceutica
Settore BIO/19
Settore CHIM/06
English
Con Impact Factor ISI
Isoxazoline; RNA polymerase; SARS-COV-2; Docking
Leusciatti, M., Macchi, B., Marino-Merlo, F., Mastino, A., Morra, G., Quadrelli, P. (2023). Inhibition of the RNA-dependent RNA-polymerase from SARS-CoV-2 by 6-chloropurine isoxazoline-carbocyclic monophosphate nucleotides. ACS OMEGA, 8(39), 36311-36320 [10.1021/acsomega.3c04918].
Leusciatti, M; Macchi, B; Marino-Merlo, F; Mastino, A; Morra, G; Quadrelli, P
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Leusciatti ACSomega_2023.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 6.59 MB
Formato Adobe PDF
6.59 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/343383
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact